These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
225 related articles for article (PubMed ID: 11566439)
1. 2-Methoxymethylestradiol: a new 2-methoxy estrogen analog that exhibits antiproliferative activity and alters tubulin dynamics. Brueggemeier RW; Bhat AS; Lovely CJ; Coughenour HD; Joomprabutra S; Weitzel DH; Vandre DD; Yusuf F; Burak WE J Steroid Biochem Mol Biol; 2001 Aug; 78(2):145-56. PubMed ID: 11566439 [TBL] [Abstract][Full Text] [Related]
2. Synthesis, antitubulin and antimitotic activity, and cytotoxicity of analogs of 2-methoxyestradiol, an endogenous mammalian metabolite of estradiol that inhibits tubulin polymerization by binding to the colchicine binding site. Cushman M; He HM; Katzenellenbogen JA; Lin CM; Hamel E J Med Chem; 1995 Jun; 38(12):2041-9. PubMed ID: 7783135 [TBL] [Abstract][Full Text] [Related]
3. Antitumor activity of a novel antiestrogen (Analog II) on human breast cancer cells. Jain PT; Rajah TT; Pento JT Anticancer Drugs; 1997 Nov; 8(10):964-73. PubMed ID: 9436640 [TBL] [Abstract][Full Text] [Related]
4. Novel estrogenic action of the pesticide residue beta-hexachlorocyclohexane in human breast cancer cells. Steinmetz R; Young PC; Caperell-Grant A; Gize EA; Madhukar BV; Ben-Jonathan N; Bigsby RM Cancer Res; 1996 Dec; 56(23):5403-9. PubMed ID: 8968093 [TBL] [Abstract][Full Text] [Related]
5. Estrogenic effects of genistein on the growth of estrogen receptor-positive human breast cancer (MCF-7) cells in vitro and in vivo. Hsieh CY; Santell RC; Haslam SZ; Helferich WG Cancer Res; 1998 Sep; 58(17):3833-8. PubMed ID: 9731492 [TBL] [Abstract][Full Text] [Related]
6. Synthesis and biological evaluation of 4-(hydroxyalkyl)estradiols and related compounds. Lovely CJ; Bhat AS; Coughenour HD; Gilbert NE; Brueggemeier RW J Med Chem; 1997 Nov; 40(23):3756-64. PubMed ID: 9371241 [TBL] [Abstract][Full Text] [Related]
7. Adaptive hypersensitivity to estradiol: potential mechanism for secondary hormonal responses in breast cancer patients. Santen R; Jeng MH; Wang JP; Song R; Masamura S; McPherson R; Santner S; Yue W; Shim WS J Steroid Biochem Mol Biol; 2001 Dec; 79(1-5):115-25. PubMed ID: 11850215 [TBL] [Abstract][Full Text] [Related]
8. The effect of exchanging various substituents at the 2-position of 2-methoxyestradiol on cytotoxicity in human cancer cell cultures and inhibition of tubulin polymerization. Cushman M; Mohanakrishnan AK; Hollingshead M; Hamel E J Med Chem; 2002 Oct; 45(21):4748-54. PubMed ID: 12361402 [TBL] [Abstract][Full Text] [Related]
9. Comparison of the effects of a pure steroidal antiestrogen with those of tamoxifen in a model of human breast cancer. Osborne CK; Coronado-Heinsohn EB; Hilsenbeck SG; McCue BL; Wakeling AE; McClelland RA; Manning DL; Nicholson RI J Natl Cancer Inst; 1995 May; 87(10):746-50. PubMed ID: 7563152 [TBL] [Abstract][Full Text] [Related]
10. Steroidal affinity labels of the estrogen receptor. 3. Estradiol 11 beta-n-alkyl derivatives bearing a terminal electrophilic group: antiestrogenic and cytotoxic properties. Lobaccaro C; Pons JF; Duchesne MJ; Auzou G; Pons M; Nique F; Teutsch G; Borgna JL J Med Chem; 1997 Jul; 40(14):2217-27. PubMed ID: 9216841 [TBL] [Abstract][Full Text] [Related]
11. Expression of estrogen receptor (ER)-alpha and ER-beta in normal and malignant prostatic epithelial cells: regulation by methylation and involvement in growth regulation. Lau KM; LaSpina M; Long J; Ho SM Cancer Res; 2000 Jun; 60(12):3175-82. PubMed ID: 10866308 [TBL] [Abstract][Full Text] [Related]
12. Immune-deficient animals to study "hormone-dependent" breast and endometrial cancer. Jordan VC; Gottardis MM; Robinson SP; Friedl A J Steroid Biochem; 1989; 34(1-6):169-76. PubMed ID: 2626014 [TBL] [Abstract][Full Text] [Related]
13. Cellular targets of the anti-breast cancer agent Z-1,1-dichloro-2,3-diphenylcyclopropane: type II estrogen binding sites and tubulin. ter Haar E; Hamel E; Balachandran R; Day BW Anticancer Res; 1997; 17(3C):1861-9. PubMed ID: 9216636 [TBL] [Abstract][Full Text] [Related]
14. Design, synthesis, cytocidal activity and estrogen receptor α affinity of doxorubicin conjugates at 16α-position of estrogen for site-specific treatment of estrogen receptor positive breast cancer. Saha P; Fortin S; Leblanc V; Parent S; Asselin É; Bérubé G Steroids; 2012 Sep; 77(11):1113-22. PubMed ID: 22801351 [TBL] [Abstract][Full Text] [Related]
15. Novel antitumor effect of estradiol in athymic mice injected with a T47D breast cancer cell line overexpressing protein kinase Calpha. Chisamore MJ; Ahmed Y; Bentrem DJ; Jordan VC; Tonetti DA Clin Cancer Res; 2001 Oct; 7(10):3156-65. PubMed ID: 11595710 [TBL] [Abstract][Full Text] [Related]
17. Anti-proliferative and anti-estrogenic effects of ICI 164,384 and ICI 182,780 in 4-OH-tamoxifen-resistant human breast-cancer cells. Coopman P; Garcia M; Brünner N; Derocq D; Clarke R; Rochefort H Int J Cancer; 1994 Jan; 56(2):295-300. PubMed ID: 8314314 [TBL] [Abstract][Full Text] [Related]
18. Estradiol dimer inhibits tubulin polymerization and microtubule dynamics. Jurášek M; Černohorská M; Řehulka J; Spiwok V; Sulimenko T; Dráberová E; Darmostuk M; Gurská S; Frydrych I; Buriánová R; Ruml T; Hajdúch M; Bartůněk P; Dráber P; Džubák P; Drašar PB; Sedlák D J Steroid Biochem Mol Biol; 2018 Oct; 183():68-79. PubMed ID: 29803726 [TBL] [Abstract][Full Text] [Related]
19. Estrogenic effects of nonylphenol on pS2, ER and MUC1 gene expression in human breast cancer cells-MCF-7. Ren L; Marquardt MA; Lech JJ Chem Biol Interact; 1997 Apr; 104(1):55-64. PubMed ID: 9158695 [TBL] [Abstract][Full Text] [Related]
20. Differential effects of estradiol and its analogs on cyclin D1 and CDK4 expression in estrogen receptor positive MCF-7 and estrogen receptor-transfected MCF-10AEwt5 cells. Hong J; Shah NN; Thomas TJ; Gallo MA; Yurkow EJ; Thomas T Oncol Rep; 1998; 5(5):1025-33. PubMed ID: 9683804 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]